Exchange: NYSEMkt·Updated 01:07 PM EDT
PLX logo

PLX Protalix BioTherapeutics Inc.

$2.66
$0.035
(1.34%)
Today
Reported EarningsAug 12
Mkt Cap$211.1M
Vol389,809.00

About PLX

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
49

Neutral Sentiment

How do you feel about PLX?

Advertisement|Remove ads.